Navigation Links
Surfaxin in Medical Technology

Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies' Annual Meeting

Surfaxin Phase 2 BPD Clinical Data Selected and Presented as Platform Presentation Aerosurf Utilizing Chrysalis Aerosol-Generator Technology Demonstrates Optimal Functional Activity WARRINGTON, Pa., May 8, 2007 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced that resul...

Discovery's KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties

...monstrates Novel Anti-Inflammatory Properties New surfaxin Data Presented At the 2007 Pediatric Academic Soci...earch. The following studies were presented: * surfaxin (KL-4 surfactant) Protects Human Airway Epithelium...tro cell-culture model. The authors concluded that surfaxin reduced the inflammatory response and therefore im...

Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics

...-derived surfactants, Survanta(r) and Curosurf(r). surfaxin is pending approval and has received an Approvable...ory." Key Data Highlights: * Treatment with surfaxin significantly improved survival (p=0.05) through o...al-derived surfactants, Survanta and Curosurf. * surfaxin significantly improved survival (p=0.04) through o...
Surfaxin in other areas

Fight ARDS - Buy DSCO For FDA Approval Tomorrow

Surfaxin. Discovery Labs' first product based on KL4 technology is SURFAXIN® ... SURFAXIN® (lucinactant) is an investigational drug product not approved for use, ...

Surfaxin

Letter for Surfaxin for the prevention of Respiratory Distress Syndrome (RDS) in ... potential approval of the Surfaxin New Drug Application (NDA) ...

Surfaxin New Drug Application

Surfaxin information includes news, clinical trial results and side effects. ... Discovery Labs Reports On Surfaxin End of Review Meeting With FDA - July 2, 2009 ...

Surfaxin

Surfaxin Biological ... Surfaxin is comprised of four active pharmaceutical ingredients ... We are positioning Surfaxin, the first peptide-containing, ...

FDA rejects Discovery Labs' Surfaxin - FierceBiotech

Shares of Discovery Laboratories plunged today as the FDA announced that it wouldn't approve the company's drug Surfaxin for treatment of respiratory illness in ...

Surfaxin for respiratory diseases by Discovery Laboratories.

Surfactants are compositions, which are produced naturally in the lungs and essential for breathing. ... SURFAXIN ... Surfaxin, if approved, would be the ...
Other Tags
(Date:7/9/2014)... a reputation for being highly toxic, but when used in ... found to offer potential health benefits in a range of ... new compound (AP39), designed and made at the University of ... delivery of very small amounts of the substance to the ... Exeter have already found that the compound protects mitochondria ...
(Date:7/9/2014)... liver is one of the most important organs in ... we utilize our food properly this is its ... from our organism this is its detoxification function. ... unhealthy food all damage the liver. The resulting diseased ... cirrhoses, and life-threatening liver failure. According to the German ...
(Date:7/9/2014)... labels handed out by pharmacists may be misread ... according to new research by the University of ... Blind)., The study, published recently in the ... prescription medications dispensed by pharmacies do not consistently ... simply following recommended guidelines for font size, use ...
(Date:7/9/2014)... , , , , , ... , , , , ... assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , , ... , , , , , , ...
(Date:7/9/2014)... The occurrence of allergic diseases has risen dramatically in ... are less exposed to microorganisms and have fewer infections ... system. , A study by researchers at Sahlgrenska Academy, ... three to examine maturation of the immune system in ... in rural areas of the Vstra Gtaland Region, half ...
Breaking Medicine News(10 mins):Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7
(Date:7/9/2014)... July 9, 2014Biofuels derived from the oils produced by ... fuels. To achieve this goal, optimization of cost effective ... pond systems, is needed. Sapphire Energy has developed an ... pond algae cultivation systems, described in Industrial Biotechnology ... publishers. The article is available on the Industrial ...
(Date:7/9/2014)... Cancer Genome Atlas (TCGA) Research Network have identified ... lung adenocarcinoma, the most common subtype of lung ... the number of possible therapeutic targets for this ... patients with treatable mutations because many potent cancer ... TCGA is jointly funded and managed by the ...
(Date:7/9/2014)... era of increasing concern about the prevalence of ... a promising new pathway to disabling disease: blocking ... The scientists showed how bacterial siderophore, a small ... to fan bacterial growth as well as ... this infection process. Their findings appear in a ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Bacteria hijack plentiful iron supply source to flourish 2
Other Contents